# FDA Inspection 1175659 - Nancy L. Bartlett, MD - June 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/nancy-l-bartlett-md/525523ff-16d1-44ef-8dc5-e0de46e61c12
Source feed: FDA_Inspections

> FDA Inspection 1175659 for Nancy L. Bartlett, MD on June 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175659
- Company Name: Nancy L. Bartlett, MD
- Inspection Date: 2022-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 983028 - 2016-08-26](https://www.keypedia.com/records/fda_inspections/nancy-l-bartlett-md/243e779c-122c-49e5-b8ad-a05f340d1263)
- [FDA Inspection 950341 - 2015-11-20](https://www.keypedia.com/records/fda_inspections/nancy-l-bartlett-md/e74ba6c3-5cff-4bce-bb5e-2ce94a89c6c0)

Company: https://www.keypedia.com/companies/nancy-l-bartlett-md/7ef5aa51-a5c6-44b5-b5ee-09825b7549ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c